ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

NCI Must Build a Research Community In Pancreatic Cancer, Review Groups Says.

March 9, 2001

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007